These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10747834)

  • 1. Endothelial cell compatibility of trovafloxacin and levofloxacin for intravenous use.
    Armbruster C; Robibaro B; Griesmacher A; Vorbach H
    J Antimicrob Chemother; 2000 Apr; 45(4):533-5. PubMed ID: 10747834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of imipenem and meropenem on purine content of endothelial cells.
    Armbruster C; Vorbach H; Robibaro B; Schaumann R; Buxbaum A; Reiter M; Georgopoulos A
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):86-9. PubMed ID: 10082172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell compatibility of clarithromycin for intravenous use.
    Vorbach H; Weigel G; Robibaro B; Armbruster C; Schaumann R; Hlousek M; Reiter M; Griesmacher A; Georgopoulos A
    Clin Biochem; 1998 Nov; 31(8):653-6. PubMed ID: 9876898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell compatibility of azithromycin and erythromycin.
    Vorbach H; Armbruster C; Robibaro B; Griesmacher A; El-Menyawi I; Daxecker H; Raab M; Müller MM
    J Antimicrob Chemother; 2002 Feb; 49(2):407-9. PubMed ID: 11815590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell compatibility of fluoroquinolone solutions for intravenous use.
    Vorbach H; Weigel G; Robibaro B; Schaumann R; Hlousek M; Beil WJ; Griesmacher A; Georgopoulos A; Graninger W
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):235-8. PubMed ID: 9208338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
    Ernst ME; Ernst EJ; Klepser ME
    Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
    Rolston KV; Ho DH; LeBlanc B; Streeter H; Dvorak T
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing.
    Perry AC; Prpa B; Rouse MS; Piper KE; Hanssen AD; Steckelberg JM; Patel R
    Clin Orthop Relat Res; 2003 Sep; (414):95-100. PubMed ID: 12966282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
    Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
    Bauernfeind A
    J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers.
    Stein GE; Schooley S
    Int J Antimicrob Agents; 2004 Aug; 24(2):168-72. PubMed ID: 15288316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of purines on endothelial high energy phosphates.
    Griesmacher A; De Abreu RA; Müller MM
    Adv Exp Med Biol; 1994; 370():527-30. PubMed ID: 7660962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro.
    Holtom PD; Pavkovic SA; Bravos PD; Patzakis MJ; Shepherd LE; Frenkel B
    J Orthop Res; 2000 Sep; 18(5):721-7. PubMed ID: 11117292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
    Klepser ME; Ernst EJ; Petzold CR; Rhomberg P; Doern GV
    Antimicrob Agents Chemother; 2001 Mar; 45(3):673-8. PubMed ID: 11181341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.
    Felmingham D; Robbins MJ; Ingley K; Mathias I; Bhogal H; Leakey A; Ridgway GL; Grüneberg RN
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():43-9. PubMed ID: 9222069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
    Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
    Dembry LM; Farrel PA; Orcutt DR; Gerrity LA; Andriole VT
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():35-42. PubMed ID: 9222068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.